Concepedia

Author

Corrado Campochiaro

Vita-Salute San Raffaele UniversityORCID

Also Known As

C Campochiaro, C. Campochiaro, CORRADO CAMPOCHIARO, Campochiaro C, Campochiaro, Corrado, Chloe McAvoy, Corrado Campochiaro, E J Nossent, Edoardo Marrani, Giacomo De Luca

446

Publications

9K

Citations

44

H-Index

103

Concepts

All Affiliations

Vita-Salute San Raffaele UniversityIstituti di Ricovero e Cura a Carattere ScientificoIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleUniversity of PaduaIRCCS Ospedale San Raffaele
CC

About

Corrado Campochiaro is an author at Vita-Salute San Raffaele University specializing in medicine, pathology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

32

2.3K

2

Public Health

5

5

1.1K

3

Health Sciences

2

2

72

4

Arts

1

1

11

5

Engineering

1

1

29

Corrado Campochiaro

×

102

Publications

6.3K

Citations

39

H-Index

YearCitations

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro,

The Lancet Rheumatology

2020

991

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Corrado Campochiaro, Emanuel Della‐Torre, Giulio Cavalli,

European Journal of Internal Medicine

2020

408

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Marco Ripa, Laura Galli, Andrea Poli,

Clinical Microbiology and Infection

2020

383

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler,

The Lancet Respiratory Medicine

2021

246

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Emanuel Della‐Torre, Corrado Campochiaro, Giulio Cavalli,

Annals of the Rheumatic Diseases

2020

241

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

Giacomo De Luca, Giulio Cavalli, Corrado Campochiaro,

The Lancet Rheumatology

2020

205

Ventricular Arrhythmias in Myocarditis

Giovanni Peretto, Simone Sala, Stefania Rizzo,

Journal of the American College of Cardiology

2020

198

An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index

Zachary S. Wallace, Arezou Khosroshahi, Mollie D. Carruthers,

Arthritis Care & Research

2018

192

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri,

The Lancet Rheumatology

2021

175

IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients

Corrado Campochiaro, E. Bozzolo, Marco Lanzillotta,

Scandinavian Journal of Rheumatology

2015

167

Page 1